Regeneron Pharmaceuticals (Nasdaq: REGN) will supply an additional 1.25M treatment courses of an antibody cocktail composed of casirivimab and imdevimab to the U.S. government under a potential $2.63B agreement with the departments of Defense and Health and Human Services.
Read More »Moderna to Produce Additional COVID-19 Vaccines Under $2B Army Contract Modification
Moderna has received a six-month, $1.97B contract modification from the U.S. Army to manufacture 100M more doses of the company's messenger RNA vaccine against the novel coronavirus.
Read More »HHS, DOD Sign Agreement for Addtl 100M Doses of Pfizer-BioNTech COVID-19 Vaccine
Pfizer has entered into an agreement with the departments of Health and Human Services and Defense to provide 100M more doses of the messenger RNA-based COVID-19 vaccine that the company developed with pharmaceutical firm BioNTech.
Read More »Merck to Receive $356M US Gov’t Funds for COVID-19 Drug Manufacturing, Supply
Merck (NYSE: MRK) has reached a $356M deal with the departments of Defense and Health and Human Services to further develop and seek regulatory approval MK-7110, the biopharmaceutical firm's investigational drug for hospitalized COVID-19 patients.
Read More »DoD, HHS Sign $375M Procurement Deal for Eli Lilly COVID-19 Drug
Eli Lilly and Co. (NYSE: LLY) has received a potential $375M contract from the departments of Defense and Health and Human Services to initially supply 300K doses of bamlanivimab, an investigational monoclonal antibody drug for COVID-19.
Read More »HHS, DoD Sign $486M Deal for AstraZeneca COVID-19 Drug
AstraZeneca has secured a $486M contract from the departments of Health and Human Services and Defense to further develop and test a pair of monoclonal antibodies as potential COVID-19 treatment. The company will use the funds to conduct large-scale production and Phase 3 trials of the experimental AZD7442 combo drug to help prevent or treat SARS-CoV-2 infections, HHS said Friday.
Read More »Ology Bioservices Wins $106M Army Contract for COVID-19 Vaccine Manufacturing Support
Ology Bioservices has won a one-year, $106.3M reserve production capacity contract from the U.S. Army Contracting Command for more than 186M doses of COVID-19 vaccines and other treatments to support the Trump administration's Operation Warp Speed.
Read More »CDC, McKesson Extend Vaccine Distribution Partnership
The Centers for Disease Control and Prevention will move to exercise an option under a 2016 contract with Irving, Texas-based health care company McKesson (NYSE: MCK) for the distribution of vaccines and associated supplies intended for pandemic vaccination efforts.
Read More »HHS, DoD Ink $1.5B Deal With Moderna for COVID-19 Vaccine Production
The departments of Health and Human Services and Defense have signed a potential $1.5B agreement with Moderna to produce 100M doses of its COVID-19 vaccine candidate as part of the U.S. government’s Operation Warp Speed.
Read More »Johnson & Johnson Secures $1B in Federal Vaccine Production Funding
Johnson & Johnson (NYSE: JNJ) has received $1B in U.S. government funding for large-scale production of a potential COVID-19 vaccine as part of the White House’s Operation Warp Speed.
Read More »